Dorsey Wright & Associates - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 302 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Dorsey Wright & Associates ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$2,256,000
+17.1%
14,441
-0.9%
0.32%
+39.4%
Q2 2014$1,927,000
+17.3%
14,575
-2.2%
0.23%
-0.9%
Q1 2014$1,643,000
+9.4%
14,896
-5.6%
0.23%
+4.6%
Q4 2013$1,502,00015,7790.22%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 300,000$34,482,00018.91%
NORTH RUN CAPITAL, LP 490,000$56,321,0005.02%
Visium Asset Management, LP 3,076,092$353,568,0004.99%
BOW STREET LLC 112,979$12,986,0004.60%
1492 Capital Management LLC 62,397$7,172,0004.49%
CLOVIS CAPITAL MANAGEMENT LP 115,000$13,218,0003.70%
Paulson & Co. 5,806,000$667,342,0003.45%
HealthCor Management, L.P. 525,000$60,344,0003.36%
SPHERA FUNDS MANAGEMENT LTD. 158,500$18,218,0003.10%
AMI ASSET MANAGEMENT CORP 299,276$34,399,0003.01%
View complete list of SALIX PHARMACEUTICALS INC shareholders